215 related articles for article (PubMed ID: 31396294)
1. Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women.
Lou WZ; Jiang F; Hu J; Chen XX; Song YN; Zhou XY; Liu JT; Bian XM; Gao JS
Dis Markers; 2019; 2019():6270187. PubMed ID: 31396294
[TBL] [Abstract][Full Text] [Related]
2. sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain).
Perales A; Delgado JL; de la Calle M; García-Hernández JA; Escudero AI; Campillos JM; Sarabia MD; Laíz B; Duque M; Navarro M; Calmarza P; Hund M; Álvarez FV;
Ultrasound Obstet Gynecol; 2017 Sep; 50(3):373-382. PubMed ID: 27883242
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of angiogenic markers in pregnancy with fetal growth restriction.
Palmrich P; Kalafat E; Pateisky P; Schirwani-Hartl N; Haberl C; Herrmann C; Khalil A; Binder J
Ultrasound Obstet Gynecol; 2024 May; 63(5):619-626. PubMed ID: 37774098
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal assessment of angiogenic markers in prediction of adverse outcome in women with confirmed pre-eclampsia.
Binder J; Palmrich P; Kalafat E; Haberl C; Schirwani N; Pateisky P; Khalil A
Ultrasound Obstet Gynecol; 2023 Dec; 62(6):843-851. PubMed ID: 37265117
[TBL] [Abstract][Full Text] [Related]
5. Decision Threshold for Kryptor sFlt-1/PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting.
Andersen LLT; Helt A; Sperling L; Overgaard M
J Am Heart Assoc; 2021 Sep; 10(17):e021376. PubMed ID: 34459248
[TBL] [Abstract][Full Text] [Related]
6. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol.
Hund M; Allegranza D; Schoedl M; Dilba P; Verhagen-Kamerbeek W; Stepan H
BMC Pregnancy Childbirth; 2014 Sep; 14():324. PubMed ID: 25230734
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic imbalance in pre-eclampsia and fetal growth restriction: enhanced soluble fms-like tyrosine kinase-1 binding or diminished production of placental growth factor?
Kluivers ACM; Biesbroek A; Visser W; Saleh L; Russcher H; Danser AHJ; Neuman RI
Ultrasound Obstet Gynecol; 2023 Apr; 61(4):466-473. PubMed ID: 36191149
[TBL] [Abstract][Full Text] [Related]
8. Urinary sFlt-1 and PlGF as preeclampsia predictors: sFlt-1/creatinine ratio improves the prediction value.
Martín-Palumbo G; Alcorta MD; de Aguado MP; Antolín E; Bartha JL
Eur J Obstet Gynecol Reprod Biol; 2024 Jul; 298():53-60. PubMed ID: 38728842
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic biomarkers for the follow-up of singleton pregnancies with suspected preeclampsia.
Gómez Fernández C; Otero Naveiro A; Raña Mayán A; Álvarez Fernández R; Pérez Fernández R; Paz Fernández E
Minerva Obstet Gynecol; 2023 Oct; 75(5):412-423. PubMed ID: 35758095
[TBL] [Abstract][Full Text] [Related]
10. The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome.
Schaarschmidt W; Rana S; Stepan H
J Perinat Med; 2013 Sep; 41(5):511-6. PubMed ID: 23612628
[TBL] [Abstract][Full Text] [Related]
11. Maternal Blood Angiogenic Factors and the Prediction of Critical Adverse Perinatal Outcomes Among Small-for-Gestational-Age Pregnancies.
Swissa SS; Walfisch A; Yaniv-Salem S; Pariente G; Hershkovitz R; Szaingurten-Solodkin I; Shashar S; Beharier O
Am J Perinatol; 2024 Jul; 41(9):1185-1194. PubMed ID: 35292946
[TBL] [Abstract][Full Text] [Related]
12. A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia.
Pant V; Yadav BK; Sharma J
BMC Pregnancy Childbirth; 2019 Jul; 19(1):266. PubMed ID: 31345176
[TBL] [Abstract][Full Text] [Related]
13. Prediction using serum glycosylated fibronectin of imminent pre-eclampsia in women with new-onset hypertension.
Sokratous N; Bednorz M; Wright A; Nicolaides KH; Kametas NA
Ultrasound Obstet Gynecol; 2023 Nov; 62(5):653-659. PubMed ID: 37606310
[TBL] [Abstract][Full Text] [Related]
14. Prediction of preterm birth in growth-restricted and appropriate-for-gestational-age infants using maternal PlGF and the sFlt-1/PlGF ratio-A prospective study.
Hong J; Crawford K; Cavanagh E; da Silva Costa F; Kumar S
BJOG; 2024 Jul; 131(8):1089-1101. PubMed ID: 38196326
[TBL] [Abstract][Full Text] [Related]
15. Impact of physical activity on preeclampsia and angiogenic markers in the Finnish Genetics of Pre-eclampsia Consortium (FINNPEC) cohort.
Jaatinen N; Ekholm E; Laivuori FH; Jääskeläinen T
Ann Med; 2024 Dec; 56(1):2325480. PubMed ID: 38466911
[TBL] [Abstract][Full Text] [Related]
16. Effects of age on the diagnostic value of the soluble fms-like tyrosine kinase-1/ placental growth factor ratio in preeclampsia: a retrospective cohort study.
Rezk M; Grasegger L; Hamzic E; Enengl S; Altmann R; Stelzl P; Oppelt P; Arbeithuber B
J Hypertens; 2023 Aug; 41(8):1258-1264. PubMed ID: 37115818
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal changes of angiogenic factors as a potential predictive tool in women with suspected preeclampsia.
Montenegro-Martínez J; Camacho-Carrasco A; Nuñez-Jurado D; Beltrán-Romero LM; Fatela-Cantillo D
Pregnancy Hypertens; 2024 Mar; 35():66-72. PubMed ID: 38245918
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of angiogenic factors and their association with preeclampsia among pregnant women at Mulago National Referral Hospital in Uganda.
Nabweyambo S; Sande OJ; McGovern N; Bwanga F; Ssekagiri A; Keesiga A; Adroma M; Wasswa R; Atuheirwe M; Namugenyi J; Castelnuovo B; Nakimuli A
PLoS One; 2021; 16(5):e0251227. PubMed ID: 34010327
[TBL] [Abstract][Full Text] [Related]
19. The role of the soluble fms-like tyrosine kinase-1/placental growth factor (sFlt-1/PIGF) - ratio in clinical practice in obstetrics: diagnostic and prognostic value.
Melo DCS; Sousa RP; Pais MSJDR; Felix LM; Pinto FF; Moura JPSA
J Perinat Med; 2023 Sep; 51(7):896-903. PubMed ID: 37163520
[TBL] [Abstract][Full Text] [Related]
20. The addition of the sFlt-1/PlGF ratio to the protein/creatinine ratio in multiple pregnancy: Post-hoc analysis of the PREPARE cohort study.
Wind M; Dekker L; van den Akker-van Marle ME; Ballieux BEPB; Cobbaert CM; Rabelink TJ; van Lith JMM; Teng YKO; Sueters M
Pregnancy Hypertens; 2024 Jun; 36():101111. PubMed ID: 38387424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
